Skip to content

Treatment of Mutrashmari (Urinary Stone)with Ashmarihara Kwath and Palasha Kshara.

A Further Study of Ashmarihara Kwath and Palasha Kshara in the Management of Mootrashmari with special reference to Urolithiasis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/03/005603
Enrollment
30
Registered
2015-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pain in renal angle and loin region radiating towards groin, burning micturation, haematuria, radiological and USG evidence of stone size up to 16mm.

Interventions

Intervention1: Group A Ashmarihara kwatha with Palasha kshara: Ashmarihara kwatha Orally 40 ml TDS For 30 days Palasha kshara Orally 500 mg (in capsule) BD For 30 days Control Intervention1: Group B

Sponsors

IPGTRA JAMNAGAR GUJARAT AYURVED UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient ages beteen 16 to 70 years having pain in renal angle and loin region , radiating towards groin , burning micturation , mild haematuria radiological and USG evidence of stone , stone size upto 15 mm, urolithiatic patient with controlled hypertension and diabetic mellitus , crystals of stone

Exclusion criteria

Exclusion criteria: 1. Renal failure. 2. Gross Hydronephrosis. 3. Acute pain abdomen. 4. Cases which requires surgical intervention. 5. Severe Haematuria. 6. Stone size more than 15 mm. 7. Known cases of Malignancy. 8. Known cases of Tuberculosis. 9. Known cases of HIV positive. 10. Known cases of VDRL positive. 11. Known cases of Hepatitis-B positive

Design outcomes

Primary

MeasureTime frame
Assessment will be done on the basis of relief in sign symptoms and other investigation findings of laboratory as well as radiologicalTimepoint: 30 days

Secondary

MeasureTime frame
Assessment will be done on the basis of relief in sign symptoms and other investigation findings of laboratory as well as radiologicalTimepoint: 30 days

Countries

India

Contacts

Public ContactDr S K Gupta

IPGTRA GAU Jamnagar

drskgupta17@gmail.com9428317639

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026